DekaBank Deutsche Girozentrale’s Seres Therapeutics MCRB Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio MCRB Stock Details MCRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,350	Closed	-$482K	–	1402
2022 Q1	$482K	Hold	3,350	–	–	﹤0.01%	1067
2021 Q4	$577K	Buy	3,350 +100	+3%	+$15.9K	﹤0.01%	1067
2021 Q3	$438K	Hold	3,250	–	–	﹤0.01%	1080
2021 Q2	$1.53M	Hold	3,250	–	–	﹤0.01%	791
2021 Q1	$1.25M	Buy	+3,250	New	+$1.5M	﹤0.01%	846
2019 Q3	–	Sell	-1,630	Closed	-$94K	–	1073
2019 Q2	$94K	Buy	1,630 +640	+65%	+$60.7K	﹤0.01%	1089
2019 Q1	$168K	Buy	990 +175	+21%	+$21.3K	﹤0.01%	1062
2018 Q4	$75K	Sell	815 -175	-18%	-$24.5K	﹤0.01%	1102
2018 Q3	$168K	Hold	990	–	–	﹤0.01%	1084
2018 Q2	$182K	Hold	990	–	–	﹤0.01%	1055
2018 Q1	$147K	Sell	990 -25	-2%	-$4.79K	﹤0.01%	1021
2017 Q4	$274K	Hold	1,015	–	–	﹤0.01%	907
2017 Q3	$274K	Hold	1,015	–	–	﹤0.01%	913
2017 Q2	$236K	Buy	+1,015	New	+$208K	﹤0.01%	919
2016 Q3	–	Sell	-1,015	Closed	-$606K	–	999
2016 Q2	$606K	Buy	1,015 +175	+21%	+$103K	0.01%	646
2016 Q1	$422K	Buy	+840	New	+$438K	0.01%	689

Other funds holding MCRB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

DekaBank Deutsche Girozentrale's MCRB Position: Q2 2022 in Review

DekaBank Deutsche Girozentrale sold out of Seres Therapeutics (MCRB) in Q2 2022, closing a stake of 3,350 shares — an estimated $482K sold.

DekaBank Deutsche Girozentrale first reported a position in MCRB in Q1 2016 and held it in 16 quarters. The position peaked at $1.53M in Q2 2021. 123 funds tracked by Wall St. Rank hold MCRB as of Q2 2022.

DekaBank Deutsche Girozentrale reported no remaining Seres Therapeutics position as of Q2 2022 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 3,350 Seres Therapeutics shares in Q2 2022, an estimated $482K.
DekaBank Deutsche Girozentrale first reported a position in Seres Therapeutics in Q1 2016 and held it in 16 quarters.
DekaBank Deutsche Girozentrale's Seres Therapeutics position peaked at $1.53M in Q2 2021.
123 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2022, filed 3 Aug 2022.